Last edition
News about Global Pharma
Intas Pharmaceuticals Acquires UDENYCA from Coherus BioSciences
Intas Pharmaceuticals, along with its global subsidiaries operating under the Accord brand, has acquired UDENYCA (pegfilgrastim-cbqv) from Coherus BioSciences, strengthening its global biosimilar portfolio and strengthening its position in the pegfilgrastim market.
Global Pharma | 07/08/2025 | By Mrinmoy Dey | 275
Kashiv Biosciences, MS Pharma Partner to Commercialise Xolair Biosimilar in MENA Region
Kashiv BioSciences and MS Pharma have entered into an exclusive licensing and supply agreement for the commercialization of ADL-018, Kashiv’s biosimilar candidate to XOLAIR (bOmalizumab) in the Middle East and North Africa (MENA) region.
Global Pharma | 07/08/2025 | By Dineshwori | 249
Sanofi Acquires Vigil Neuroscience, Strengthens Neurodegenerative Disease Pipeline
Sanofi has completed its acquisition of Vigil Neuroscience, thereby strengthening its early-stage pipeline in neurology with the addition of VG-3927, an experimental drug candidate for Alzheimer's disease.
Global Pharma | 07/08/2025 | By Dineshwori | 290
Pharmexcil Invites Indian Pharma Companies to Explore Opportunities in Mexico at Virtual Meet
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has invited its member companies to participate in a virtual meet on "Mexico: Expansion Opportunities for the Indian Pharmaceutical Industry."
Global Pharma | 06/08/2025 | By Dineshwori | 365
Intas Pharmaceuticals has launched HETRONIFLY (Serplulimab), the world’s first PD-1 inhibitor approved for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in the Indian market.
Global Pharma | 06/08/2025 | By Mrinmoy Dey | 393
Polpharma Biologics, Fresenius Kabi Partners to Commercialise A Proposed Vedolizumab Biosimilar
Polpharma Biologics, a European biotechnology company, has entered into a global licensing agreement with German multinational healthcare firm Fresenius Kabi for the commercialisation of PB016—a proposed biosimilar to vedolizumab.
Global Pharma | 06/08/2025 | By Dineshwori | 299
Governor of New York State Kathy Hochul has announced that Garonit Pharmaceutical, a global manufacturer of antiseptic products and health care solutions, will establish a state-of-the-art, 200,000-square-foot pharmaceutical manufacturing facility in New Windsor, Orange County.
Global Pharma | 05/08/2025 | By Dineshwori | 311
Viatris Appoints David Simmons to the Company's Board of Directors
Viatris Inc. has appointed seasoned pharma executive David Simmons to its Board of Directors, bringing decades of global leadership, R&D, and capital markets experience to support the company’s strategic growth.
Global Pharma | 05/08/2025 | By Mrinmoy Dey | 225
Laborate Pharmaceuticals Achieves EU-GMP Certification for Paonta Sahib Manufacturing Facility
Laborate Pharmaceuticals has announced that its state-of-the-art manufacturing facility in Paonta Sahib, Himachal Pradesh, has been awarded the EU-GMP (European Union - Good Manufacturing Practice) certification by the relevant European regulatory authority.
Global Pharma | 05/08/2025 | By Dineshwori | 702
US Tariffs on EU Pharma Imports Threaten Drug Access and Innovation, GlobalData Warns
The US-EU trade deal has placed the pharmaceutical industry under significant fiscal strain, with consequences that extend beyond short-term financials, according to GlobalData, a leading data and analytics company.
Global Pharma | 05/08/2025 | By Dineshwori | 265
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy